Insights
Insights From Our Experts
Articles
Case Study: Leveraging Machine Learning Models in Patient Identification and Behavior Prediction for Rare Disease Indications
When a mid-sized pharmaceutical company was challenged with trial and adoption of their immune thrombocytopenia (ITP) drug due to fierce competition and the lingering impact of COVID-19, they turned to the team of data and analytics…
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Rare diseases are complex, and with limited research available, therapeutic options are often limited. Gene therapy, a growing area of clinical research, is showing great promise in treatment that may be life-altering for patients with many…
Navigating the Complexities of Patient Care with Digital and Human Touchpoints
Three Key Objectives Guide Program Development: Access, Affordability and Adherence Patients taking branded therapies to manage long-term health conditions are faced with a dizzying array of challenges, all of which can hinder access to medication, create…
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
As rare diseases become an increasing area of global focus, pharmaceutical manufacturers are taking a closer look at how patient-reported outcomes (PROs) may be used to improve uptake in HTA evaluations. Although “rare” suggests not many…
QUIZ: How Mature Are Your HCP & Patient Engagement Strategies?
In the increasingly virtual world we live in, there’s no denying the instrumental role that technology plays in engaging patients and healthcare providers (HCPs). With heavier reliance across industries on text alerts, automated phone reminders and…
Aligning Net Pricing with Patient Outcomes – Removing Barriers to Value-Based Contracting
While value-based contracting has long been heralded as a way to ensure the cost of life-changing and life-saving medicines are aligned with patient outcomes, the complexity in their implementation has limited adoption to just a few…
WEBINAR: Reimagining the Patient Journey for CGTs: Informing, Engaging and Empowering the Patient Population
Posted by
Seth Gordon on December 2, 202112/2/21
Cell and gene therapies (CGTs) hold great life-saving and therapeutic advancement potential, but their complexity requires careful approach–starting with engaging and educating patient communities earlier. While the patient’s voice should be a guiding force throughout the…
Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer
Nearly 32% of Americans suffer from complex, chronic or rare conditions, such as autoimmune diseases, genetic disorders or cancer, many of which require a specialty prescription therapy. Despite being only 3% of overall prescriptions, specialty medications…